Glenn Mcdowell Sells 2,900 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) Stock

U.S. Physical Therapy, Inc. (NYSE:USPH) COO Glenn Mcdowell sold 2,900 shares of the firm’s stock in a transaction that occurred on Thursday, March 15th. The shares were sold at an average price of $82.55, for a total transaction of $239,395.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Glenn Mcdowell also recently made the following trade(s):

How to Become a New Pot Stock Millionaire
  • On Tuesday, March 13th, Glenn Mcdowell sold 2,743 shares of U.S. Physical Therapy stock. The shares were sold at an average price of $86.11, for a total transaction of $236,199.73.

NYSE USPH opened at $85.00 on Friday. U.S. Physical Therapy, Inc. has a 12 month low of $56.50 and a 12 month high of $87.50. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.28. The company has a market cap of $1,070.66, a P/E ratio of 41.11, a P/E/G ratio of 3.10 and a beta of 1.08.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings data on Thursday, March 8th. The company reported $0.49 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.49. The business had revenue of $109.20 million for the quarter, compared to analyst estimates of $104.12 million. U.S. Physical Therapy had a net margin of 5.38% and a return on equity of 13.12%. sell-side analysts predict that U.S. Physical Therapy, Inc. will post 2.44 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 13th. Shareholders of record on Wednesday, March 21st will be given a $0.23 dividend. This is a positive change from U.S. Physical Therapy’s previous quarterly dividend of $0.20. The ex-dividend date is Tuesday, March 20th. This represents a $0.92 annualized dividend and a yield of 1.08%. U.S. Physical Therapy’s payout ratio is 44.23%.

Several equities research analysts have commented on USPH shares. Jefferies Group set a $76.00 price target on shares of U.S. Physical Therapy and gave the company a “hold” rating in a research note on Friday, February 23rd. Cantor Fitzgerald restated a “buy” rating and issued a $80.00 price target on shares of U.S. Physical Therapy in a research note on Tuesday, January 9th. Zacks Investment Research upgraded shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $89.00 price objective on the stock in a research note on Wednesday, March 7th. Barrington Research reiterated a “hold” rating on shares of U.S. Physical Therapy in a research note on Friday, March 9th. Finally, ValuEngine upgraded shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating in a research note on Monday, April 2nd. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. U.S. Physical Therapy currently has an average rating of “Hold” and a consensus target price of $79.40.

Institutional investors have recently bought and sold shares of the business. SG Americas Securities LLC acquired a new position in U.S. Physical Therapy in the third quarter worth approximately $170,000. UBS Asset Management Americas Inc. acquired a new position in U.S. Physical Therapy in the fourth quarter worth approximately $206,000. Envestnet Asset Management Inc. grew its position in U.S. Physical Therapy by 48.6% in the fourth quarter. Envestnet Asset Management Inc. now owns 3,704 shares of the company’s stock worth $267,000 after buying an additional 1,212 shares during the last quarter. Ladenburg Thalmann Financial Services Inc. grew its position in U.S. Physical Therapy by 59.9% in the third quarter. Ladenburg Thalmann Financial Services Inc. now owns 3,770 shares of the company’s stock worth $231,000 after buying an additional 1,412 shares during the last quarter. Finally, Trustcore Financial Services LLC acquired a new position in U.S. Physical Therapy in the fourth quarter worth approximately $296,000. Hedge funds and other institutional investors own 96.53% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Glenn Mcdowell Sells 2,900 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) Stock” was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this article on another domain, it was stolen and reposted in violation of United States and international trademark & copyright legislation. The original version of this article can be accessed at https://www.dispatchtribunal.com/2018/04/07/insider-selling-u-s-physical-therapy-inc-usph-coo-sells-2900-shares-of-stock.html.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Insider Buying and Selling by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply